Literature DB >> 28599503

Effects of inflammatory factors including plasma tumor necrosis factor-α in the clinical treatment of acute respiratory distress syndrome.

Shu Ran Huang1,2, Ai Ying Ma2, Yuan Liu1, Yan Qu1.   

Abstract

The present study investigated the association between the levels of plasma tumor necrosis factor-α (TNF-α), interleukin (IL)-6, IL-8, high-sensitivity C-reactive protein and fibrinogen levels of patients with acute respiratory distress syndrome (ARDS) with ARDS treatment outcome and duration of mechanical ventilation, with the aim of improving the efficacy of ARDS therapy. A total of 140 patients with ARDS were randomly divided into groups A and B, with 70 patients in each group. The patients in group A received a combination of conventional treatment and comprehensive treatment (test group) and the patients in group B were treated with conventional therapy only (control group). Elbow venous blood was obtained from each patient in the morning prior to treatment, on the 3rd day of treatment and on the 5th day of treatment. The levels of inflammatory factors, the clinical effects and the duration of mechanical ventilation of the two groups were statistically analyzed. The levels of IL-6, TNF-α and IL-8 in patients from group A were significantly reduced compared with those from group B (P<0.05). Additionally, the oxygenation index and arterial partial oxygen pressure of patients in group A were significantly higher compared with group B patients (P<0.05), the duration of mechanical ventilation of group A was decreased compared with that of group B (P<0.05) and the overall response rate of group A was >90%, whereas group B had a response rate of 80.0%. These results indicate that the treatment administered to patients in group A exhibited an improved clinical efficacy. The combination of comprehensive and conventional therapy may effectively reduce the levels of inflammatory factors and the inflammatory response, and these levels may be important for the effective treatment of ARDS and in reducing treatment duration. Therefore the current study may improve upon current clinical practice.

Entities:  

Keywords:  acute respiratory distress syndrome; clinical treatment sequence; interleukin; plasma tumor necrosis factor

Year:  2017        PMID: 28599503      PMCID: PMC5453114          DOI: 10.3892/ol.2017.6090

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  9 in total

Review 1.  [Cytokine and inflammatory mediators in acute respiratory distress syndrome].

Authors:  Zhong-Ji Sun; Qing Lu; Yin-Ping Li
Journal:  Zhongguo Wei Zhong Bing Ji Jiu Yi Xue       Date:  2003-03

2.  Non-invasive ventilation for surgical patients with acute respiratory failure.

Authors:  Byoung Chul Lee; Kyu Hyouck Kyoung; Young Hwan Kim; Suk-Kyung Hong
Journal:  J Korean Surg Soc       Date:  2011-06-09

3.  Revisiting signs, strengths and weaknesses of Standard Chest Radiography in patients of Acute Dyspnea in the Emergency Department.

Authors:  Luciano Cardinale; Giovanni Volpicelli; Alessandro Lamorte; Jessica Martino
Journal:  J Thorac Dis       Date:  2012-08       Impact factor: 2.895

4.  [Exploration of the theory of "Fei and Dachang being interior-exteriorly related" from observing changes of inflammatory cytokines and oxygen free radicals in the lung tissue of ulcerative colitis rats].

Authors:  Xin Yan; Xin-Yue Wang; Yi-Hua Sheng; Li Zhu; Liang-Deng Zhang; Qin Zang
Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi       Date:  2014-04

5.  IL-8 inhibits cAMP-stimulated alveolar epithelial fluid transport via a GRK2/PI3K-dependent mechanism.

Authors:  Jérémie Roux; Carmel M McNicholas; Michel Carles; Arnaud Goolaerts; Benjamin T Houseman; Dale A Dickinson; Karen E Iles; Lorraine B Ware; Michael A Matthay; Jean-François Pittet
Journal:  FASEB J       Date:  2012-12-06       Impact factor: 5.191

6.  Propofol Protects Rats and Human Alveolar Epithelial Cells Against Lipopolysaccharide-Induced Acute Lung Injury via Inhibiting HMGB1 Expression.

Authors:  Xiaoyan Wang; Chengxiao Liu; Gongming Wang
Journal:  Inflammation       Date:  2016-06       Impact factor: 4.092

7.  Comparison of chest computed tomography features in the acute phase of cardiogenic pulmonary edema and acute respiratory distress syndrome on arrival at the emergency department.

Authors:  Kosaku Komiya; Hiroshi Ishii; Junji Murakami; Hidehiko Yamamoto; Fumito Okada; Katashi Satoh; Osamu Takahashi; Kazunori Tobino; Kazuya Ichikado; Takeshi Johkoh; Jun-Ichi Kadota
Journal:  J Thorac Imaging       Date:  2013-09       Impact factor: 3.000

8.  Tumor Necrosis Factor-Α, Interleukin-6, C-Reactive Protein Levels and Insulin Resistance Associated with Type 2 Diabetes in Abdominal Obesity Women.

Authors:  Surapon Tangvarasittichai; Suthap Pongthaisong; Orathai Tangvarasittichai
Journal:  Indian J Clin Biochem       Date:  2015-07-26

Review 9.  The standard of care of patients with ARDS: ventilatory settings and rescue therapies for refractory hypoxemia.

Authors:  Thomas Bein; Salvatore Grasso; Onnen Moerer; Michael Quintel; Claude Guerin; Maria Deja; Anita Brondani; Sangeeta Mehta
Journal:  Intensive Care Med       Date:  2016-04-04       Impact factor: 17.440

  9 in total
  3 in total

1.  Pharmacological agents for adults with acute respiratory distress syndrome.

Authors:  Sharon R Lewis; Michael W Pritchard; Carmel M Thomas; Andrew F Smith
Journal:  Cochrane Database Syst Rev       Date:  2019-07-23

2.  Serum interleukin-18: A novel prognostic indicator for acute respiratory distress syndrome.

Authors:  Guangsu Dong; Fei Wang; Liang Xu; Min Zhu; Bin Zhang; Bin Wang
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

3.  Correlations of IL-17 and NF-κB gene polymorphisms with susceptibility and prognosis in acute respiratory distress syndrome in a chinese population.

Authors:  Meimei Xie; Bihuan Cheng; Yueping Ding; Changliang Wang; Jianshi Chen
Journal:  Biosci Rep       Date:  2019-02-08       Impact factor: 3.840

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.